Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
Activity Details
|
|
126 *
|
Mon, 7/31/2017,
8:30 AM -
10:20 AM
|
CC-342
|
Diagnostics, Classification, and Agreement — Contributed Papers
|
Section on Medical Devices and Diagnostics , Section on Statistics in Imaging
|
Chair(s): Gene Pennello, Food and Drug Administration
|
8:35 AM
|
Detection of Prostate Cancer with Multi-Parametric MR Imaging Models Utilizing the Anatomic Structure of the Prostate
—
Jin Jin, University of Minnesota ; Joseph Koopmeiners, University of Minnesota ; Lin Zhang, University of Minnesota ; Greg Metzger, University of Minnesta ; Ethan Leng, University of Minnesta
|
8:50 AM
|
Overall Unscaled Indices for Assessing Agreement Among Multiple Raters
—
Jeong Hoon Jang, Emory University ; Amita Manatunga, Emory University ; Qi Long, University of Pennsylvania
|
9:05 AM
|
Combining Biomarkers by Maximizing the True Positive Rate for a Fixed False Positive Rate
—
Allison Meisner, University of Washington ; Marco Carone, University of Washington Department of Biostatistics ; Margaret Pepe, Fred Hutchinson Cancer Research Center ; Katie Kerr, University of Washington Department of Biostatistics
|
9:20 AM
|
Does Correlation Matter: The Influence of Correlation on Diagnostic Test Performance at the Optimal Point
—
Beau Nunnally, Air Force Institute of Technology ; Christine M Schubert, Air Force Institute of Technology/ENC ; Katherine A Batterton, Air Force Institute Technology
|
9:35 AM
|
Sample Size and Confidence Interval Planning for Estimating the Optimal Thresholds in a Sequence of Diagnostic Tests
—
Christine M Schubert, Air Force Institute of Technology/ENC ; Donna McClish, VCU ; Amber R Wilk, Virginia Commonwealth University
|
9:50 AM
|
Choosing Between the BP and BN Sequential Strategies
—
Donna McClish, VCU ; Christine Schubert Kabban, Air Force Institute of Technology ; Amber R Wilk, Virginia Commonwealth University
|
10:05 AM
|
Evaluating Classification Performance of Biomarkers in Two-Phase Case-Control Studies
—
Lu Wang, Fred Hutchinson Cancer Research Center ; Ying Huang, Fred Hutchinson Cancer Research Center
|
|